BiologicalDrug
COVID-19 Vaccine Gam-COVID-Vac clinical trials
- studies test it
- 11
- open now
- 0
- in phase 3
- 5
- first study started
- 2020
How studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2020 (7)
| Year | Studies |
|---|---|
| 2020 | 7 |
| 2021 | 3 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 7
- Phase 3
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 10
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation (7) · Ministerio de Salud de Ciudad Autónoma de Buenos Aires (3) · Dr. Reddy's Laboratories Limited (1)
Studies
Open first, then newest update. How each study uses COVID-19 Vaccine Gam-COVID-Vac is read from its arms, and is right about nine times in ten.
Testing it · 11
- Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal SprayStatus unknownPhase 1/2Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian FederationNCT05248373Written as Gam-COVID-Vac
- Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines.Status unknownPhase 2Ministerio de Salud de Ciudad Autónoma de Buenos AiresNCT05027672Written as Gam-COVID-Vac (rAd26) / Gam-COVID-Vac (rAd5)
- Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine SchemesCompletedPhase 2Ministerio de Salud de Ciudad Autónoma de Buenos AiresNCT04962906Written as Gam-COVID-Vac / Gam-COVID-Vac
- Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly PopulationStatus unknownPhase 2Ministerio de Salud de Ciudad Autónoma de Buenos AiresNCT04983537Written as Gam-COVID-Vac / Gam-COVID-Vac
- Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) InfectionStatus unknownPhase 2/3Dr. Reddy's Laboratories LimitedNCT04640233Written as Gam-COVID-Vac
- Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19Status unknownPhase 3Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian FederationNCT04530396Written as Gam-COVID-Vac
- The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and OlderStatus unknownPhase 2Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian FederationNCT04587219Written as Gam-COVID-Vac
- A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAEStatus unknownPhase 3Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian FederationNCT04656613Written as Gam-COVID-Vac
- Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in BelarusStatus unknownPhase 3Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian FederationNCT04564716Written as Gam-COVID-Vac
- Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in VenezuelaStatus unknownPhase 3Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian FederationNCT04642339Written as Gam-COVID-Vac
- An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19CompletedPhase 1/2Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian FederationNCT04436471Written as Gam-COVID-Vac